Delivery Order SPE2DR25D3103-SPE2DR26F9F37
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Temozolomide 140 mg capsules (14-count units) with a ceiling value of $3,561.36. This is a firm fixed-price delivery order with an ultimate completion date of November 3, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Temozolomide 100 mg capsules (quantity 14) with a ceiling value of $3,358.08. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 21, 2025. The award represents a continuation of AmerisourceBergen's extensive role in federal...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for Temozolomide 250 mg capsules in quantities of five, with a ceiling value of $1,043.74. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location and completed by August 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $2,375.97 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 14 capsules of Temozolomide 180 mg. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 17, 2023 through August 18, 2023. Temozolomide is a chemotherapy drug used to treat certain types of brain tumors. This delivery order was awarded under an existing DLA pharmaceutical...
- The Defense Logistics Agency awarded a $1,619.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 250 mg temozolomide capsules. Under this order, Amerisourcebergen will deliver 5 boxes of the chemotherapy drug to a facility in Conshohocken, Pennsylvania by September 19, 2023. As the Defense Logistics Agency is responsible for procuring medical supplies and pharmaceuticals for the U.S. military and other government agencies, this order is likely intended...
- The Defense Logistics Agency awarded a $100,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 5,000 Temozolomide 5 mg capsules to support the Department of Defense's medical supply needs. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by July 28, 2023 to fulfill requirements under the agency's pharmaceutical supply vehicle. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $282,850 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of temozolomide 180 mg capsules. Under this order, Amerisourcebergen will deliver 5 lots of the chemotherapy drug to a location in Conshohocken, Pennsylvania by July 19, 2023 to support the Department of Defense's medical supply needs. As a top 50 contractor on the DLA's Pharmaceutical Prime Vendor contract, which provides pharmaceuticals and medical supplies to...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $298.80 to Amerisourcebergen Drug Corp for the supply of 100 mg temozolomide capsules. As the prime contractor, Amerisourcebergen Drug Corp will deliver 5 boxes of the chemotherapy medication to its Conshohocken, Pennsylvania facility on behalf of the Defense Logistics Agency, the logistics combat support agency of the United States Department of Defense. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $188,050 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 180 mg temozolomide capsules. Under this contract, Amerisourcebergen will deliver 5 lots of the chemotherapy medication to a location in Conshohocken, Pennsylvania by July 3, 2023 to support the Department of Defense's medical supply needs. As a top 50 contractor on the DLA's Pharmaceutical Prime Vendor program, Amerisourcebergen routinely provides...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,316 to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 180 mg temozolomide capsules to be delivered to a location in Conshohocken, Pennsylvania by July 20, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and works to provide medical supplies and pharmaceuticals to support military readiness. This small order for...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9F37Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,221.00 to AmerisourceBergen Drug Corp for the supply of Temozolomide 100 mg capsules (14-count units) on November 13, 2025, with an ultimate completion date of November 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Temozolomide is an oral chemotherapy medication used primarily in the treatment of certain brain cancers, including glioblastoma multiforme, supporting the Defense Health Agency's pharmaceutical supply requirements for military healthcare beneficiaries. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle valued through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, leveraging its extensive capabilities to deliver a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide. The company's consistent award history and competitive positioning in DLA's pharmaceutical supply chain demonstrate its operational capacity to fulfill federal medical needs across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/13/25 |